News & Views

IT Solutions Focus

Oct 26 2007

Author: Kim Shah, Thermo Fisher Scientific and Ajit Nagral, Megaware Inc. on behalf of Unassigned Independent Article

Free to read

This article has been unlocked and is ready to read.

Download

Rapid market growth in generic drug manufacture is driving the requirement for fast efficient bioequivalence studies to meet FDA ANDA (Abbreviated New Drug Application) guidelines. Bioequivalence studies are a critical component of ANDA submissions. The purpose of these studies is to demonstrate pharmaceutical equivalence between a generic drug product and the corresponding reference listed drug. Establishing bioequivalence allows for a regulatory conclusion of therapeutic equivalence [1]. According to IMS Health, global generics sales are increasing by 19% per year [2]. A generic is the bioequivalent of an original pharmaceutical product, whose patent has expired. Generics are much cheaper to produce than the original brand on which they are based. Once a product has lost patent protection, it is replaced almost entirely within six to twelve months by generics, which are sold at 85% to 90% less than the original products [3]. This compression of the time-to-market for generics, and the extreme price sensitivity of final generic drugs means that speed and cost are major drivers for customers. The urgency to remove stages from the manufacturing process of generic drugs is more compelling than ever in order to ensure improved throughput and much easier regulatory compliance.

Free to read

This article has been unlocked and is ready to read.

Download


Digital Edition

Lab Asia 29.6 Dec

December 2022

In This Edition Chromatography - Optimising Viral Vector Purification Strategies with Multimodal Chromatography - Key UHPLC Characteristics Required for High throughput LC-MS - New Low Volu...

View all digital editions

Events

Medlab Middle East

Feb 06 2023 Dubai, UAE

FILTECH

Feb 14 2023 Cologne, Germany

SmartLab Exchange

Feb 22 2023 Amsterdam, Netherlands

SLAS 2023

Feb 25 2023 San Diego, CA, USA

View all events